|
|||||
|
|
18F-FDG PET/CT in pancreatic adenocarcinoma: A role at initial imaging staging? |
|
| Authors: | M Wartski A Sauvanet |
| Institution: | 1. Department of Nuclear Medicine, Université de Paris – Paris Descartes, Cochin Hospital-AP–HP, 27, rue du Faubourg Saint-Jacques, 75014 Paris, France;2. Department of Hepato-Pancreato-Biliary Surgery, Pôle des Maladies de l’Appareil Digestif, Université de Paris-Paris Diderot, Beaujon Hospital, 92110 Clichy, France |
| Abstract: | Pancreatic ductal adenocarcinoma represents 90% of all pancreatic tumors. The only hope for prolonged survival in patients with this condition still remains surgery with complete R0 resection. Initial imaging has a pivotal role to identify patients who are eligible to curative surgery and those who may benefit of neoadjuvant chemotherapy. This review provides an analysis of the recent literature on 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in pancreatic adenocarcinoma. Performances of FDG PET in the detection of lymph node involvement and metastatic spread at initial staging and those in the assessment of response to treatment are described. |
| Keywords: | Corresponding author Pancreatic adenocarcinoma 18F-Fluorodeoxyglucose positron emission tomography (FDG PET/CT) Imaging |
| 本文献已被 ScienceDirect 等数据库收录！ | |